跳至主要内容
临床试验/NCT04926961
NCT04926961已完成不适用

Testing the Contribution of Orbitofrontal Cortex Networks to Reward Identity Learning

Northwestern University1 个研究点 分布在 1 个国家目标入组 42 人开始时间: 2021年6月16日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
42
试验地点
1
主要终点
Blood oxygen level-dependent (BOLD) responses

研究概览

简要总结

This research study examines the contribution of orbitofrontal cortex (OFC) networks to learning reward identity expectations.

详细描述

This study is designed to examine the contribution of OFC networks to reward identity learning. It will use network-targeted TMS to test whether OFC is necessary for reward identity learning. Healthy human subjects will perform a three-reward reversal learning task after either TMS or sham stimulation while fMRI data are acquired. This is a randomized, within-subject, cross-over study.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Basic Science
盲法
Single (Participant)

入排标准

年龄范围
18 Years 至 50 Years(Adult)
性别
All
接受健康志愿者
是

入选标准

  • •Age between 18 and 50 years old
  • •Right-handed
  • •Fluent English speakers

排除标准

  • •History of significant neurological conditions (e.g., epilepsy, dementia, multiple sclerosis, brain tumors, etc.)
  • •History of major psychiatric conditions (e.g., general anxiety disorder, depression, schizophrenia, obsessive-compulsive disorder, post-traumatic stress disorder, attention deficit hyperactivity disorder, alcoholism, etc.)
  • •Significant medical illnesses (e.g., cancer, meningitis, chronic obstructive pulmonary disease, cardiovascular disease, etc.)
  • •Significant cerebrovascular risk factors (e.g., hypertension, diabetes, elevated cholesterol, etc.)
  • •Current use of psychoactive medications (e.g., barbiturates, benzodiazepines, chloral hydrate, haloperidol, lithium, carbamazepine, phenytoin, citalopram, escitalopram, fluoxetine, diazepam, etc.)
  • •Smell or taste dysfunction
  • •History of significant allergies requiring hospitalization for treatment
  • •History of severe asthma requiring hospitalization for treatment
  • •Habitual smoking
  • •Magnetic implants (e.g., shunts or stents, aneurysm clips, surgical clips, cochlear implants, metal bone/joint pins, plates and screws, eyelid spring or wires, etc.)
  • •Electronic devices (e.g., implanted cardiac defibrillator, cardiac pacemaker, deep brain/spinal cord or nerve stimulator, internal electrodes/wires, medication infusion devices, etc.)
  • •History of metal working without proper eye protection, or injury with metal shrapnel or metal slivers
  • •Claustrophobia
  • •Pregnancy
  • •Predisposition to seizures (e.g., personal history of seizures, family history of seizures epilepsy, pregnancy, alcoholism, etc.)
  • •Use of medications that increase the likelihood of seizures (e.g., bupropion, citalopram, duloxetine, ketamine, gamma-hydroxybutyrate, etc.)
  • •History of surgical procedures performed on the brain or spinal cord
  • •History of severe head trauma followed by loss of consciousness
  • •History of fainting spells or syncope
  • •Hearing problems or tinnitus

研究组 & 干预措施

Real stimulation first, then sham stimulation

Experimental

Participants will first be delivered real TMS stimulation. Then on a separate day, participants will be delivered sham TMS stimulation.

干预措施: Sham transcranial magnetic stimulation (TMS) (Device)

Real stimulation first, then sham stimulation

Experimental

Participants will first be delivered real TMS stimulation. Then on a separate day, participants will be delivered sham TMS stimulation.

干预措施: Real transcranial magnetic stimulation (TMS) (Device)

Sham stimulation first, then real stimulation

Experimental

Participants will first be delivered sham TMS stimulation. Then on a separate day, participants will be delivered real TMS stimulation.

干预措施: Sham transcranial magnetic stimulation (TMS) (Device)

Sham stimulation first, then real stimulation

Experimental

Participants will first be delivered sham TMS stimulation. Then on a separate day, participants will be delivered real TMS stimulation.

干预措施: Real transcranial magnetic stimulation (TMS) (Device)

结局指标

主要结局

Blood oxygen level-dependent (BOLD) responses

时间窗: 1 hour

Blood oxygen level-dependent (BOLD) responses measured using functional magnetic resonance imaging (fMRI) during the reversal learning task.

Percentage of correct outcome predictions

时间窗: 1 hour

Percentage of correct outcome predictions in response to predictive cues during the reversal learning task.

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Christina Zelano

Assistant Professor

Northwestern University

研究点 (1)

Loading locations...

相似试验